
PRODUCT OVERVIEW:
Cagrilintide is a long-acting amylin analogue that supports appetite regulation and weight optimization by activating amylin and calcitonin receptors. It enhances stability and efficacy, promoting satiety and reducing food intake. Clinical studies, especially in combination with semaglutide (CagriSema), show superior results in weight loss and glycemic control for obesity and type 2 diabetes.
The information provided above is not intended to substitute medical advice, diagnosis, or treatment. Should you have any questions regarding a medical condition, seek the advice of your physician or a qualified healthcare provider.
In no case should medical advice be disregarded or delayed because of what you have read or seen. We bear no responsibility or liability for your use of any of our research compounds and products. Please note that they are being sold for research purposes ONLY. We do NOT condone any personal use.
Additional Notes:
Have a question about our research-only compounds or quality standards?
Reach out using the form below. Our team responds with compliant guidance for laboratory and analytical inquiries.